BamSEC and AlphaSense Join Forces
Learn More

Yarrow Bioscience Inc. – Articles of Incorporation

NASDAQ: YARW    
Share price (8/7/26): $41.43    
Market cap (8/7/26): $116 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.5
from 8-K 27 pages Amended and Restated Bylaws of Yarrow Bioscience, Inc
12/34/56
EX-3.4
from 8-K 5 pages Amended and Restated Certificate of Incorporation of Yarrow Bioscience, Inc
12/34/56
EX-3.3
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of VYNE Therapeutics Inc
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of VYNE Therapeutics Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of VYNE Therapeutics Inc
12/34/56
EX-3.2
from S-4 20 pages Corporate Offices
12/34/56
EX-3.1
from S-4 22 pages Amended and Restated Certificate of Incorporation of Yarrow Bioscience, Inc
12/34/56
EX-3.2
from DRS 20 pages Bylaws of Yarrow Bioscience, Inc. (The “Corporation”) Adopted On: October 3, 2025
12/34/56
EX-3.1
from DRS 22 pages Amended and Restated Certificate of Incorporation of Yarrow Bioscience, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of VYNE Therapeutics Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Elimination of Series a Convertible Preferred Stock of VYNE Therapeutics Inc. Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 10-Q 26 pages Amended and Restated Bylaws of VYNE Therapeutics Inc. (A Delaware Corporation) Effective November 10, 2022
12/34/56
EX-3.1(B)
from 10-Q 13 pages VYNE Therapeutics Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 10-K 10 pages Menlo Therapeutics Inc. Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of VYNE Therapeutics Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 10-K 9 pages Menlo Therapeutics Inc. Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of VYNE Therapeutics Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 10-Q 7 pages Menlo Therapeutics Inc. Amended and Restated Certificate of Incorporation
12/34/56
EX-3.2
from 8-K 25 pages Amended and Restated Bylaws of VYNE Therapeutics Inc. (A Delaware Corporation) Effective September 4, 2020
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Menlo Therapeutics Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56